RE:RE:RE:RE:Shareprice Sirona probably could have got $80,000/kg in an exclusive deal with R+F since that would be an input cost of only $2.40 on a tube that sells for $66 but the non-exclusive deal means Sirona can not sell the ingredient to R+F at a higher price than it will to R+F's competitors who make lower priced tubes. Sirona mgmt, get on with signing more clients.
lscfa wrote:
1 kg = 10,000 50ml tubes = 33,333 15ml tubes.
3 mil customers x 4 tubes/yr = 12 million tubes.
12 million tubes / 33,333 = 360 kg/yr.
360 kg x $8000 usd x 1.25 = $3,6 mil cdn per yr
forhandlaren wrote: Based on the NR's at least two batches of 20kg have been produced in France - probably more - and at least one much bigger (volume unknown) in China.
Each kilo represents 500 000 ml - Howard has stated 10000 tubes of 50 ml, but R+F put it in 15 ml.
Their market is currently 300K agents with 2 million customers, but they have just started to build their business in Japan. In addition there's internet sales not tied to the agents. Let's assume 3 million users.
Most of the users will try the product at least once, many of them on a regular basis. Let's assume 50 percent and 4 tubes annually (60 ml).
1 500 000 users x 60 ml = 90 million ml
90 million ml / 500 000 = 180 kg
180 kg x 10 000 CAD = 1 800 000 CAD
The revenue will cover about 50 percent of the burn rate (including production costs).
I assume that the primary goal with the R+F deal is to get street cred and revenue is welcome but secondary.
The upcoming multiple deals with this low concentration should be more profitable, not to mention the pharmaceutical grade in the works with clinical results due withon a week or two.